Research keywords (4):
悪性リンパ腫
, 血小板
, 造血幹細胞
, 造血器腫瘍
Research theme for competitive and other funds (1):
2022 - 2025 治癒を目指したCML幹細胞の特性解析
Papers (26):
Takahiro Haeno, Shinya Rai, Yoshiaki Miyake, Maiko Inoue, Ko Fujimoto, Aki Fujii, Yoshio Iwata, Shuji Minamoto, Takahide Taniguchi, Hiroaki Kakutani, et al. Long-term effectiveness and safety of high dose chemotherapy followed by autologous stem cell transplantation in daily practice in patients with diffuse large B-cell lymphoma. Journal of clinical and experimental hematopathology : JCEH. 2023. 63. 2. 99-107
口分田 貴裕. SUMO化阻害薬とrituximabのマクロファージおよびNK細胞活性-The activity of macrophage and NK cell induced by the combined treatment with SUMOylation inhibitor and rituximab. 血液内科 = Hematology / 血液内科編集委員会 編. 2023. 86. 2. 235-239
Ryosuke Fujiwara, Yasuhiro Taniguchi, Shinya Rai, Yoshio Iwata, Aki Fujii, Ko Fujimoto, Takahiro Kumode, Kentaro Serizawa, Yasuyoshi Morita, J Luis Espinoza, et al. Chlorpromazine cooperatively induces apoptosis with tyrosine kinase inhibitors in EGFR-mutated lung cancer cell lines and restores the sensitivity to gefitinib in T790M-harboring resistant cells. Biochemical and biophysical research communications. 2022. 626. 156-166
Takahiro Kumode, Hirokazu Tanaka, Jorge Luis Esipinoza, Shinya Rai, Yasuhiro Taniguchi, Ryosuke Fujiwara, Keigo Sano, Kentaro Serizawa, Yoshio Iwata, Yasuyoshi Morita, et al. C-type lectin-like receptor 2 specifies a functionally distinct subpopulation within phenotypically defined hematopoietic stem cell population that contribute to emergent megakaryopoiesis. International journal of hematology. 2022. 115. 3. 310-321
THE JAPAN SOCIETY OF TRANSFUSION MEDICINE AND CELL THERAPY
, 日本臨床腫瘍学会
, 日本リンパ網内系学会
, 日本造血細胞移植学会
, THE JAPANESE SOCIETY OF HEMATOLOGY
, THE JAPANESE SOCIETY OF INTERNAL MEDICINE